Details for Patent: 8,512,727
✉ Email this page to a colleague
Summary for Patent: 8,512,727
Title: | Nanoparticulate meloxicam formulations |
Abstract: | The present invention is directed to nanoparticulate compositions comprising meloxicam. The meloxicam particles of the composition have an effective average particle size of less than about 2000 nm. |
Inventor(s): | Cooper; Eugene R. (Berwyn, PA), Ryde; Tuula (Malvern, PA), Pruitt; John (Collegeville, PA), Kline; Laura (Harleysville, PA) |
Assignee: | Alkermes Pharma Ireland Limited (Dublin, IE) |
Application Number: | 10/784,900 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,512,727 |
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 8,512,727
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,512,727
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Austria | 431131 | ⤷ Sign Up | |||
Canada | 2517679 | ⤷ Sign Up | |||
Germany | 602004021107 | ⤷ Sign Up | |||
Denmark | 3090731 | ⤷ Sign Up | |||
Denmark | 3434261 | ⤷ Sign Up | |||
European Patent Office | 1617816 | ⤷ Sign Up | |||
European Patent Office | 1938803 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |